 Bilirubin
"Bilirubin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bile pigment that is a degradation product of HEME.
| Descriptor ID |
D001663
|
| MeSH Number(s) |
D03.383.129.578.840.249.184 D03.633.400.909.249.184 D04.345.783.249.184 D23.767.193.184
|
| Concept/Terms |
Bilirubin, Calcium Salt- Bilirubin, Calcium Salt
- Calcium Salt Bilirubin
- Salt Bilirubin, Calcium
- Calcium Bilirubinate
- Bilirubinate, Calcium
|
Below are MeSH descriptors whose meaning is more general than "Bilirubin".
Below are MeSH descriptors whose meaning is more specific than "Bilirubin".
This graph shows the total number of publications written about "Bilirubin" by people in this website by year, and whether "Bilirubin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 3 | 3 | | 2008 | 0 | 2 | 2 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 1 | 1 | | 2011 | 0 | 2 | 2 | | 2012 | 0 | 6 | 6 | | 2014 | 2 | 2 | 4 | | 2015 | 2 | 2 | 4 | | 2016 | 3 | 2 | 5 | | 2017 | 1 | 1 | 2 | | 2018 | 1 | 1 | 2 | | 2019 | 2 | 1 | 3 | | 2020 | 1 | 1 | 2 | | 2021 | 0 | 2 | 2 | | 2022 | 0 | 1 | 1 | | 2023 | 0 | 7 | 7 | | 2024 | 2 | 1 | 3 | | 2025 | 5 | 2 | 7 | | 2026 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Bilirubin" by people in Profiles.
-
Satrom KM, Kerns E, Schissel M, Garber M, Monti J, Bakken EH, Gallois J, Hampton EP, Sarathy L, Stipelman CH, Widmer KM, Magee S, Chang PW. A National Quality Improvement Collaborative to Reduce Subthreshold Phototherapy for Jaundice. Pediatrics. 2026 Jul 01; 158(1).
-
Abi-Aad SJ, Tsalatsanis A, Narkewicz M, Leung DH, Khalaf RT. The Impact of Elexacaftor-Tezacaftor-Ivacaftor on Biochemical Surrogates of Cystic Fibrosis Hepatobiliary Involvement: A Retrospective Cohort Study. Pediatr Pulmonol. 2026 Feb; 61(2):e71522.
-
Chatzipanagiotou OP, Catalano G, Mujtaba K, Kawashima J, Altaf A, Cauchy F, Aucejo F, Marques HP, Lam V, Hugh T, Popescu I, Kitago M, Weiss M, Martel G, Ratti F, Poultsides GA, Ruzzenente A, Endo I, Gleisner A, Pawlik TM. Perioperative changes in ALBI and platelets (CAP): association with postoperative complications among patients undergoing surgery for hepatocellular carcinoma. HPB (Oxford). 2026 Mar; 28(3):389-398.
-
Akabane M, Baldo A, Kawashima J, Woldesenbet S, Lesurty M, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC. Eur J Surg Oncol. 2026 Feb; 52(2):111309.
-
Bryant AK, Rice JD, Morris E, Parikh ND, Cuneo K, Dawson LA, Stanescu T, Mayo C, Lawrence TS, Schipper M. The Contribution of Cirrhosis Progression in Liver Dysfunction After Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2026 Jun 01; 125(2):473-480.
-
Björk D, Carling U, Gilg S, Hasselgren K, Larsen PN, Lindell G, Røsok BI, Sandström P, Sturesson C, Tschuor C, Sparrelid E, Björnsson B. Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization-a retrospective scandinavian cohort study. Eur J Surg Oncol. 2025 Jul; 51(7):109995.
-
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Dynamic ALBI score and FIB-4 index trends to predict complications after resection of hepatocellular carcinoma: A K-means clustering approach. Eur J Surg Oncol. 2025 Jun; 51(6):109723.
-
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Development and validation of the albumin-bilirubin gamma-glutamyl transferase score for enhanced prognostic accuracy after hepatocellular carcinoma resection. J Gastrointest Surg. 2025 04; 29(4):101984.
-
Altaf A, Khalil M, Akabane M, Rashid Z, Kawashima J, Zindani S, Ruzzenente A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Aucejo F, Kitago M, Popescu I, Martel G, Gleisner A, Bauer TW, Hugh T, Bhimani N, Shen F, Endo I, Pawlik TM. Up-front resection for hepatocellular carcinoma: Assessing futility in the preoperative setting. Eur J Surg Oncol. 2025 May; 51(5):109594.
-
Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Alexandrescu S, Popescu I, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma. HPB (Oxford). 2024 Nov; 26(11):1369-1378.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|